Skip to content

Clinical trials

Phase 3 Lymphoma, B-Cell, Marginal Zone trials in Belgium

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, B-Cell, Marginal Zone Phase: Phase 3 Country / region: Belgium Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20031
20141
20212
20221
20232

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4
Active, not recruiting2
Recruiting2
Terminated2
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
European Organisation for Research and Treatment of Cancer - EORTC4
BeOne Medicines1
Incyte Corporation1
International Extranodal Lymphoma Study Group (IELSG)1
Janssen Research & Development, LLC1
MEI Pharma, Inc.1
Regeneron Pharmaceuticals1
The Lymphoma Academic Research Organisation1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, B-Cell, Marginal Zone11
Lymphoma, Follicular9
Leukemia, Lymphocytic, Chronic, B-Cell4
Lymphoma4
Lymphoma, Non-Hodgkin4
Burkitt Lymphoma3
Leukemia, Myeloid, Acute3
Lymphoma, Large B-Cell, Diffuse3
Lymphoma, Large-Cell, Immunoblastic3
Lymphoma, Mantle-Cell3

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.